These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20348452)

  • 1. Calcium dobesilate and oxerutin: effectiveness of combination therapy.
    Akbulut B
    Phlebology; 2010 Apr; 25(2):66-71. PubMed ID: 20348452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial.
    Rabe E; Jaeger KA; Bulitta M; Pannier F
    Phlebology; 2011 Jun; 26(4):162-8. PubMed ID: 21478142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium dobesilate for chronic venous insufficiency: a systematic review.
    Ciapponi A; Laffaire E; Roqué M
    Angiology; 2004; 55(2):147-54. PubMed ID: 15026869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M
    Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Stuard S; Corsi M
    Angiology; 2005; 56(2):165-72. PubMed ID: 15793606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency of the lower limbs.
    Arceo A; Berber A; Treviño C
    Angiology; 2002; 53(5):539-44. PubMed ID: 12365860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind multicentre clinical trial comparing the efficacy of calcium dobesilate with placebo in the treatment of chronic venous disease.
    Martínez-Zapata MJ; Moreno RM; Gich I; Urrútia G; Bonfill X;
    Eur J Vasc Endovasc Surg; 2008 Mar; 35(3):358-65. PubMed ID: 17962050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM; Hamberg O; Sørensen MD; Neland K
    Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
    Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled, clinical study on the efficacy and safety of calcium dobesilate in the treatment of chronic venous insufficiency.
    Rabe E; Ballarini S; Lehr L;
    Phlebology; 2016 May; 31(4):264-74. PubMed ID: 25991692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium dobesilate in the treatment of primary venous insufficiency of the lower limbs. A controlled clinical study].
    Pecchi S; De Franco V; Damiani P; Guerrini M; Di Perri T
    Clin Ter; 1990 Mar; 132(6):409-17. PubMed ID: 2139387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
    Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
    Ippolito E; Belcaro G; Dugall M; Cesarone MR; Feragalli B; Errichi BM; Gizzi G; Pellegrini L; Ledda A; Luzzi R; Ricci A; Bavera P; Hosoi M; Corsi M; Errichi S
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):13-9. PubMed ID: 22108472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double blind, placebo-controlled clinical trial to evaluate the lymphagogue effect and clinical efficacy of calcium dobesilate in chronic venous disease.
    Flota-Cervera F; Flota-Ruiz C; Treviño C; Berber A
    Angiology; 2008; 59(3):352-6. PubMed ID: 18388097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial.
    Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S25-8. PubMed ID: 12011970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open trial of calcium dobesilate in patients with venous ulcers and stasis dermatitis.
    Kaur C; Sarkar R; Kanwar AJ; Attri AK; Dabra AK; Kochhar S
    Int J Dermatol; 2003 Feb; 42(2):147-52. PubMed ID: 12709007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind trial of calcium dobesilate in chronic venous insufficiency.
    Casley-Smith JR
    Angiology; 1988 Oct; 39(10):853-7. PubMed ID: 3177951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.